Clinical Trial Update: A Phase 3, Multi-Center Study Evaluating PL9643 in Patients with Dry Eye [Phase 3]

View source ↗

Summary

Phase 3, multi-center trial evaluating PL9643 in dry eye has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Dry Eye Syndrome

Drugs mentioned

• PL9643

Snippet

Sponsor: Palatin Technologies, Inc | Conditions: Dry Eye, Dry Eye Syndromes | Phase 3 | Status: COMPLETED